Search

Your search keyword '"Fontas, E."' showing total 383 results

Search Constraints

Start Over You searched for: Author "Fontas, E." Remove constraint Author: "Fontas, E."
383 results on '"Fontas, E."'

Search Results

3. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

6. Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study

7. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

9. Prospective multicenter evaluation of Luminal Apposing Metallic Stent for endoscopic pancreatic necrosectomy: The Diabolopig Trial

11. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents

12. How to RESPOND to modern challenges for people living with HIV: A profile for a new cohort consortium

13. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

14. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

15. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

16. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

18. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

21. Observational cohort study of rilpivirine (RPV) utilization in Europe

22. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

24. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

30. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents

36. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

39. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

43. Pharmacorésistance aux psychotropes chez l’enfant et l’adolescent et recherche d’anomalies pharmacogénétiques du cytochrome P450 2D6. Vers une médecine personnalisée en pédopsychiatrie ?

45. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

47. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

48. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

49. Efficacité et tolérance en « vie réelle » des inhibiteurs de checkpointsen situation adjuvante dans le mélanome : étude observationnelle monocentrique rétrospective

50. Nivolumab combiné à une radiothérapie multisite hypofractionnée dans le mélanome avancé naïf de traitement (NIRVANA) : essai de phase 2 non-randomisé, ouvert et multicentrique

Catalog

Books, media, physical & digital resources